FDA grants fast-track vouchers to three psychedelic firms
read at Endpoints ↗RegulatoryPositive
The FDA announced it has issued fast-track development vouchers to three companies working on psychedelic therapies.
The recipients are R&DCompass, Transcend, and the Usona Institute. The vouchers are intended to accelerate the regulatory review of new psychedelic drug candidates.
Wall Street analysts said the selections were unexpected, highlighting the agency’s growing interest in psychedelic medicines.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “FDA unveils three psychedelic-focused commissioner vouchers”
read at Endpoints ↗86 words · retrieved Apr 26
comments(0)
5-min edit window · permanent after that